DIAGNOSTIC VALUE OF FUSION OF METABOLIC AND STRUCTURAL IMAGES FOR STEREOTACTIC BIOPSY OF BRAIN TUMORS WITHOUT ENHANCEMENT AFTER CONTRAST MEDIUM INJECTION.
Fiche publication
Date publication
septembre 2019
Journal
Neuro-Chirurgie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NAMER Izzie-Jacques, Dr LHERMITTE Benoît, Dr CEBULA Hélène, Pr PROUST François
Tous les auteurs :
Todeschi J, Bund C, Cebula H, Chibbaro S, Lhermitte B, Pin Y, Lefebvre F, Izzie JN, Proust F
Lien Pubmed
Résumé
The heterogeneous nature of glioma makes it difficult to select a target for stereotactic biopsy that will be representative of grade severity on non-contrast-enhanced lesion imaging. The objective of this study was to evaluate the benefit of fusion of metabolic images (PET F-DOPA) with magnetic resonance imaging (MRI) morphological images for cerebral biopsy under stereotactic conditions of glioma without contrast enhancement.
Mots clés
(18)F-FDOPA PET, PET-MRI image registration, biopsy target, brain tumor, glioma target
Référence
Neurochirurgie. 2019 Sep 24;: